Sex steroid receptors in human myometrium and fibroids: Changes during the menstrual cycle and gonadotropin-releasing hormone treatment

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 11, 1998, Pages 4092-4096

  Englund, Katarina ^a   Blanck, Agneta ^a   Gustavsson, Inger ^a   Lundkvist, Ulrika ^b   Sjöblom, Peter ^a   Norgren, Allan ^b   Lindblom, Bo ^b,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; GONADORELIN; GOSERELIN; PROGESTERONE;

ARTICLE; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; LUTEAL PHASE; MENSTRUAL CYCLE; MYOMA; MYOMETRIUM; PRIORITY JOURNAL; TISSUE LEVEL;

EID: 0031765467     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.11.4092     Document Type: Article

References (20)

1. Stancel G, Baker W, Hyder SM, Kirkland JL, Loose-Mitchell DS. 1943 Oncogenes and uterine function. Oxf Rev Reprod Biol. 15:1-42.
2. Adamson GD. 1992 Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists. Am J Obstet Gynecol. 166:746-751.
3. Bradford MM. 1976 A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:248-254.
4. Senekjian EK, Press MF, Blough RR, Herbst AL, De Sombre ER. 1989 Comparison of the quantity of estrogen receptors in human endometrium and myometrium by steroid binding assay and enzyme immunoassay based on monoclonal antibodies to human estrophilin. Am J Obstet Gynecol. 160:592-597.
5. Sadan O, van Iddekinge B, Savage N, van der Walt LA, Zakut H. 1991 Endocrine profile associated with estrogen and progesterone receptors in leiomyoma and normal myometrium. Gynecol Endocrinol. 4:33-42.
6. Kawaguchi K, Fujii S, Konishi I, et al. 1991 Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy. Virchows Arch B Cell Pathol. 419:309-315.
7. Rein MS, Friedman AJ, Stuart JM, MacLaughlin DT. 1990 Fibroid and myometrial steroid receptors in women treated with gonadotropin-releasing hormone agonist leuprolide acetate. Fertil Steril. 53:1018-1023.
8. Vollenhoven BJ, Pearce P, Herington AC, Healy DL. 1994 Steroid receptor binding and messenger RNA expression in fibroids from untreated and gonadotrophin-releasing hormone agonist pretreated women. Clin Endocrinol (Oxf). 40:537-544.
9. Koutsilieris M. 1992 Pathophysiology of uterine leiomyomas. Biochem Cell Biol. 70:273-278.
10. Brandon DD, Erickson TE, Keenan EJ, et al. 1995 Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab. 80:1876-1881.
11. Brandon DD, Bethea CL, Strawn EY, et al. 1993 Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol. 169:78-85.
12. Schmidt-Gollwitzer M, Eiletz J, Genz T, Follow K. 1979 Determination of estradiol, estrone, and progesterone in serum and myometrium: correlation with the content of sex steroid receptors and 17β-hydroxysteroid dehydrogenase activity throughout the menstrual cycle. J Clin Endocrinol Metab. 49:370-376.
13. Okulicz WC, Savasta SM, Hoberg LM, Longcope C. 1989 Immunofluorescent analysis of estrogen induction of progesterone receptor in the rhesus uterus. Endocrinology. 125:930-934.
14. Puziga'ca C, Prelevi'c GM, Stretenovi'c Z. 1994 Differential reduction in the volume of leiomyoma and uterus during buserelin treatment. Gynecol Endocrinol. 8:39-43.
15. Watanabe Y, Nakamura G, Matsuguchi H, Nozaki M, Sano M, Nakano H. 1992 Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women. Fertil Steril. 58:66-71.
16. Schlaff WD, Zerhouni EA, Huth JA, Chen J, Damewood MD, Rock JA. 1989 A placebo-controlled trial of a depot gonadotropin-releasing hormone analogue (leuprolide) in the treatment of uterine leiomyomata. Obstet Gynecol. 74:856-862.
17. Rein MS, Barbieri RL, Friedman AJ. 1995 Progesterone. A critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol. 172:14-18.
18. Harrison-Woolrych M, Robinson R. 1995 Fibroid growth in response to high-dose progestogen. Fertil Steril. 64:191-192.
19. Alvarez-Murphy A, Kettel LM, Morales AJ, Roberts VJ, Yen SSC. 1993 Regression of uterine leiomyomata in response to the antiprogesterone RU 486. J Clin Endocrinol Metab. 76:513-517.
20. Reinsch RC, Murphy AA, Morales AJ, Yen SSC. 1994 The effects of RU 486 and leuprolide acetate on uterine artery blood flow in the fibroid uterus: a prospective, randomized study. Am J Obstet Gynecol. 170:1623-1628.